CRO Market
Trends
Drug Development Process
CRO Industry at a Glance
Key Issues
Patient Safety
Regulatory
Health Care
Therapeutic Areas
Ethics
Quality Control
Information Technology
Other Issues
Government Links
Industry Events
Select ACRO Member
ACRO Member Directory
Clinical Research Management, Inc.
Covance
Global Research Services
ICON Plc
Kendle
MDS Pharma Services
PAREXEL International
PharmaNet Development Group
PPD
PRA International
Quintiles Transnational
RPS
Member News
Benefit of Partnering
with CROs
Tufts CSDD Study
Selecting the Optimal CRO
Background Information
on Clinical Trials
Frequently Asked Questions
Glossary of Terms
ACRO Commentaries
ACRO Fact Sheet
Press Releases
Industry News
Member News
Media Contact
In The Media
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
November 2004
Reaching Patients Through the Internet
>>
Monitoring adverse events in social media for pharma’s biggest brands: hopeless task or simple project?
[Dose of Digital] 12/16/09
>>
Will patients find value in discussions with pharma marketers on social media sites?
[Pharma Marketing]
>>
Americans are burned out on health risk information
[Health Populi]
FDA Helps Pharma Grow Orphan Drugs
>>
Big pharma and the profit problem of rare diseases
[Minyanville] 12/16/09
>>
The cost of new drugs
[In The Pipeline]
>>
Patents box idea gains limited applause
[Financial Times]
Improving NDA Approval Rates with "Sunshine"
>>
Would complete disclosure cure the NDA-rejection rash?
[Fierce Biotech] 12/16/09
>>
Google and pharmacovigilance
[Eye on FDA]
>>
Better care through clinical trials
[The Health Care Blog]
FDA Under the Knife?
>>
Can FDA withstand the FY 11 budget-cutters?
[FDA Matters] 12/9/09
>>
http://invivoblog.blogspot.com/2009/12/were-not-like-nice-barks-germanys-iqwig.html
[IN VIVO Blog]
>>
Stealth comparative effectiveness in U.S.
[IN VIVO Blog]
Industry Trends
>>
Getz: Industry trends suggest more trials will go to top sites
[Bio-IT World] 12/9/09
>>
European regulators and their conflicts of interest
[Pharmalot]
>>
More states jump on HIE bandwagon
[Fierce HealthIT]
India Requiring Biometric Data
>>
India wants biometric data for trials; may enable Phase I studies
[Outsourcing-Pharma] 12/9/09
>>
Clinical trial participants are there willingly
[MedPage Today]
>>
PPD sets up central biostats platform
[Outsourcing-Pharma]
Bringing Cancer Research into the 21st Century
>>
A smarter war on cancer
[Xconomy] 12/3/09
>>
Should drug companies conduct their own clinical trials?
[PharmaTimes]
>>
What happens when doctors give patients more power?
[Reuters]
Post-Market Drug Database
>>
Public database is urged to monitor drug safety
[New York Times] 12/3/09
>>
Low-risk, high-value Health 2.0 idea: clinical trial subject alert & reminder
[The Corner Office]
>>
Continuing our conversation about health IT… a new ONC blog kicks off
[HHS]
1
Website By
Ego Id